Home

BizHyderabad

Students Den

ITHyderabad

Movie Reviews

Newsmakers

ReachoutHyderabad.com
"City News"


IDDCR partners with TUSP to bring QA/RA graduate program to students in Hyderabad

Hyderabad|India|July'2011: International Drug Discovery and Clinical Research (IDDCR) and the prestigious Temple University’s School of Pharmacy (TUSP) have joined hands in the delivery of global certificate programs to India. Starting in late August, IDDCR will bring Temple University’s globally recognized Quality Assurance/Regulatory Affairs (QA/RA) graduate program to students in Hyderabad, offering one-year Post Graduate Diploma Programs that cover key concepts in the pharmaceutical industry.

IDDCR intends to educate 80 - 100 select students in Clinical Trial Management and Global Pharmacovigilance each year. The Certificate programs will help ease the demand for high-quality Clinical Trial and Pharmacovigilance professionals from Big Pharma, Start up, Generic Drug, Biotechnology, and Clinical Research organisations in India. The certificates consist of five concentrated courses and offer students the option of pursuing the Master’s degree of Science at TUSP, USA.

Founded in 1884 in Philadelphia, PA, Temple University is the sixth largest provider of professional education in the U.S. and attracts more than 38,000 students to its 300 undergraduate and graduate programs each year. Established in 1968, its QA/RA graduate program is the oldest and most comprehensive of its type in the world. IDDCR provides practical training and resources for global biotech and pharmaceutical companies.

Vamsi Maddipatla, CEO of IDDCR announced: “We are excited to partner with Temple University in bringing their globally acknowledged certificate program in India, as our pharmaceutical industry in currently grappling with a talent crunch. Students in our Institute will be able to interface with Temple’s experienced faculty in real time. Career opportunities also will be created for qualified graduates with local, national, and international biotech companies.” Vamsi continued, “Various centers and institutions currently offer certification, but this initiative by IDDCR-Temple creates the only fully industry-focused certificate program in Clinical Trials and Pharmacovigilance in India.”

July.2011

This site is conceived, designed, and maintained by ReachoutHyderabad.com.
 All rights reserved world wide. Copyright © 1999- 2011. Mail your queries to reachouthyderabad@yahoo.com
Disclaimer:
Neither ReachoutHyderabad.com, nor the sources it obtained the information from, are responsible for the correctness /validity of the information in these pages. It is a collection of both facts and opinions. You are advised to verify all information with a reliable source before acting on it. This disclaimer applies to all pages of ReachoutHyderabad.com
Reproduction in whole or in part in any form or medium without written permission of  ReachoutHyderabad.com is prohibited.